204 related articles for article (PubMed ID: 15073121)
41. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
[TBL] [Abstract][Full Text] [Related]
42. Surfactant protein A expression in human normal and neoplastic breast epithelium.
Braidotti P; Cigala C; Graziani D; Del Curto B; Dessy E; Coggi G; Bosari S; Pietra GG
Am J Clin Pathol; 2001 Nov; 116(5):721-8. PubMed ID: 11710690
[TBL] [Abstract][Full Text] [Related]
43. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer.
McCart Reed AE; Song S; Kutasovic JR; Reid LE; Valle JM; Vargas AC; Smart CE; Simpson PT
Virchows Arch; 2013 Oct; 463(4):535-45. PubMed ID: 23942617
[TBL] [Abstract][Full Text] [Related]
44. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS
J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982
[TBL] [Abstract][Full Text] [Related]
45. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
46. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
47. Molecular characterization of breast cancer cell lines by a low-density microarray.
de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
[TBL] [Abstract][Full Text] [Related]
48. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat.
Espey LL; Yoshioka S; Russell DL; Robker RL; Fujii S; Richards JS
Biol Reprod; 2000 Apr; 62(4):1090-5. PubMed ID: 10727282
[TBL] [Abstract][Full Text] [Related]
49. Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.
Cao D; Polyak K; Halushka MK; Nassar H; Kouprina N; Iacobuzio-Donahue C; Wu X; Sukumar S; Hicks J; De Marzo A; Argani P
Breast Cancer Res; 2008; 10(5):R91. PubMed ID: 18954444
[TBL] [Abstract][Full Text] [Related]
50. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.
Weinstat-Saslow DL; Zabrenetzky VS; VanHoutte K; Frazier WA; Roberts DD; Steeg PS
Cancer Res; 1994 Dec; 54(24):6504-11. PubMed ID: 7527299
[TBL] [Abstract][Full Text] [Related]
51. Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.
Boorjian S; Tickoo SK; Mongan NP; Yu H; Bok D; Rando RR; Nanus DM; Scherr DS; Gudas LJ
Clin Cancer Res; 2004 May; 10(10):3429-37. PubMed ID: 15161698
[TBL] [Abstract][Full Text] [Related]
52. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Pusztai L; Ayers M; Stec J; Clark E; Hess K; Stivers D; Damokosh A; Sneige N; Buchholz TA; Esteva FJ; Arun B; Cristofanilli M; Booser D; Rosales M; Valero V; Adams C; Hortobagyi GN; Symmans WF
Clin Cancer Res; 2003 Jul; 9(7):2406-15. PubMed ID: 12855612
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of laminin-5 in breast carcinoma cells.
Martin KJ; Kwan CP; Nagasaki K; Zhang X; O'Hare MJ; Kaelin CM; Burgeson RE; Pardee AB; Sager R
Mol Med; 1998 Sep; 4(9):602-13. PubMed ID: 9848077
[TBL] [Abstract][Full Text] [Related]
54. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
Miki Y; Suzuki T; Kitada K; Yabuki N; Shibuya R; Moriya T; Ishida T; Ohuchi N; Blumberg B; Sasano H
Cancer Res; 2006 Jan; 66(1):535-42. PubMed ID: 16397270
[TBL] [Abstract][Full Text] [Related]
55. Identification of differentially expressed genes in oral squamous cell carcinoma.
Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
[TBL] [Abstract][Full Text] [Related]
56. Human glioblastomas overexpress ADAMTS-5 that degrades brevican.
Nakada M; Miyamori H; Kita D; Takahashi T; Yamashita J; Sato H; Miura R; Yamaguchi Y; Okada Y
Acta Neuropathol; 2005 Sep; 110(3):239-46. PubMed ID: 16133547
[TBL] [Abstract][Full Text] [Related]
57. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene.
Kuno K; Kanada N; Nakashima E; Fujiki F; Ichimura F; Matsushima K
J Biol Chem; 1997 Jan; 272(1):556-62. PubMed ID: 8995297
[TBL] [Abstract][Full Text] [Related]
58. Expression profile of genes associated with antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells.
Zhao H; Jhanwar-Uniyal M; Datta PK; Yemul S; Ho L; Khitrov G; Kupershmidt I; Pasinetti GM; Ray T; Athwal RS; Achary MP
Int J Cancer; 2004 Mar; 109(1):65-70. PubMed ID: 14735469
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
60. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
